Mitochondrial RNA modification: A novel therapeutic target to combat metastasis

Cell Biology InternationalVolume 48, Issue 3 p. 233-236 COMMENTARY Mitochondrial RNA modification: A novel therapeutic target to combat metastasis Shifang Huang, Shifang Huang Department of Pharmacology, Yongzhou Vocational Technical College, Yongzhou, China Contribution: Writing - original draftSearch for more papers by this authorHonglu Jiang, Honglu Jiang Department of Pharmacology, Yongzhou Radio and TV University, Yongzhou, China Contribution: ResourcesSearch for more papers by this authorZhen Huang, Zhen Huang The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China Contribution: ResourcesSearch for more papers by this authorYuting Li, Corresponding Author Yuting Li [email protected] Department of Pharmacology, Yongzhou Vocational Technical College, Yongzhou, China Correspondence Yuting Li, Department of Pharmacology, Yongzhou Vocational Technical College, Yongzhou 425000, China. Email: [email protected] Haoliang Hu, Zoology Key Laboratory of Hunan Higher Education, Changde Research Centre for Artificial Intelligence and Biomedicine, College of Life and Environmental Sciences, Hunan University of Arts and Science, Changde 415000, China. Email: [email protected] Contribution: Writing - review & editingSearch for more papers by this authorHaoliang Hu, Corresponding Author Haoliang Hu [email protected] orcid.org/0000-0003-4936-3411 Zoology Key Laboratory of Hunan Higher Education, Changde Research Centre for Artificial Intelligence and Biomedicine, College of Life and Environmental Sciences, Hunan University of Arts and Science, Changde, China Correspondence Yuting Li, Department of Pharmacology, Yongzhou Vocational Technical College, Yongzhou 425000, China. Email: [email protected] Haoliang Hu, Zoology Key Laboratory of Hunan Higher Education, Changde Research Centre for Artificial Intelligence and Biomedicine, College of Life and Environmental Sciences, Hunan University of Arts and Science, Changde 415000, China. Email: [email protected] Contribution: Writing - review & editingSearch for more papers by this author Shifang Huang, Shifang Huang Department of Pharmacology, Yongzhou Vocational Technical College, Yongzhou, China Contribution: Writing - original draftSearch for more papers by this authorHonglu Jiang, Honglu Jiang Department of Pharmacology, Yongzhou Radio and TV University, Yongzhou, China Contribution: ResourcesSearch for more papers by this authorZhen Huang, Zhen Huang The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China Contribution: ResourcesSearch for more papers by this authorYuting Li, Corresponding Author Yuting Li [email protected] Department of Pharmacology, Yongzhou Vocational Technical College, Yongzhou, China Correspondence Yuting Li, Department of Pharmacology, Yongzhou Vocational Technical College, Yongzhou 425000, China. Email: [email protected] Haoliang Hu, Zoology Key Laboratory of Hunan Higher Education, Changde Research Centre for Artificial Intelligence and Biomedicine, College of Life and Environmental Sciences, Hunan University of Arts and Science, Changde 415000, China. Email: [email protected] Contribution: Writing - review & editingSearch for more papers by this authorHaoliang Hu, Corresponding Author Haoliang Hu [email protected] orcid.org/0000-0003-4936-3411 Zoology Key Laboratory of Hunan Higher Education, Changde Research Centre for Artificial Intelligence and Biomedicine, College of Life and Environmental Sciences, Hunan University of Arts and Science, Changde, China Correspondence Yuting Li, Department of Pharmacology, Yongzhou Vocational Technical College, Yongzhou 425000, China. Email: [email protected] Haoliang Hu, Zoology Key Laboratory of Hunan Higher Education, Changde Research Centre for Artificial Intelligence and Biomedicine, College of Life and Environmental Sciences, Hunan University of Arts and Science, Changde 415000, China. Email: [email protected] Contribution: Writing - review & editingSearch for more papers by this author First published: 15 January 2024 https://doi.org/10.1002/cbin.12124 Shifang Huang and Honglu Jiang contributed equally to this study. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Open Research DATA AVAILABILITY STATEMENT Data openly available in a public repository that issues datasets with DOIs. REFERENCES Abad, E., García-Mayea, Y., Mir, C., Sebastian, D., Zorzano, A., Potesil, D., Zdrahal, Z., Lyakhovich, A., & Lleonart, M. E. (2019). Common metabolic pathways implicated in resistance to chemotherapy point to a key mitochondrial role in breast cancer. Molecular & Cellular Proteomics: MCP, 18, 231–244. 10.1074/mcp.RA118.001102 CASPubMedGoogle Scholar Chen, X., Li, A., Sun, B. F., Yang, Y., Han, Y. N., Yuan, X., Chen, R. X., Wei, W. S., Liu, Y., Gao, C. C., Chen, Y. S., Zhang, M., Ma, X. D., Liu, Z. W., Luo, J. H., Lyu, C., Wang, H. L., Ma, J., Zhao, Y. L., … Yang, Y. G. (2019). 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nature Cell Biology, 21, 978–990. 10.1038/s41556-019-0361-y CASPubMedWeb of Science®Google Scholar Chen, Z., Zhou, H., Hu, H., & Chen, L. (2022). Blocking the metabolic switch toward cytosolic 1C flux: A novel therapeutic approach for tumors with low SLC19A1 expression. Pathology and Oncology Research, 28, 1610337. 10.3389/pore.2022.1610337 PubMedWeb of Science®Google Scholar Delaunay, S., Pascual, G., Feng, B., Klann, K., Behm, M., Hotz-Wagenblatt, A., Richter, K., Zaoui, K., Herpel, E., Münch, C., Dietmann, S., Hess, J., Benitah, S. A., & Frye, M. (2022). Mitochondrial RNA modifications shape metabolic plasticity in metastasis. Nature, 607, 593–603. 10.1038/s41586-022-04898-5 CASPubMedWeb of Science®Google Scholar Fuentes-Retamal, S., Sandoval-Acuña, C., Peredo-Silva, L., Guzmán-Rivera, D., Pavani, M., Torrealba, N., Truksa, J., Castro-Castillo, V., Catalán, M., Kemmerling, U., Urra, F. A., & Ferreira, J. (2020). Complex mitochondrial dysfunction induced by TPP(+)-Gentisic acid and mitochondrial translation inhibition by doxycycline evokes synergistic lethality in breast cancer cells. Cells, 9, 407. 10.3390/cells9020407 CASPubMedWeb of Science®Google Scholar Hu, Y., Chen, C., Tong, X., Chen, S., Hu, X., Pan, B., Sun, X., Chen, Z., Shi, X., Hu, Y., Shen, X., Xue, X., & Lu, M. (2021). NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death & Disease, 12, 842. 10.1038/s41419-021-04127-3 CASPubMedWeb of Science®Google Scholar Huang, Z., Pan, J., Wang, H., Du, X., Xu, Y., Wang, Z., & Chen, D. (2021). Prognostic significance and tumor immune microenvironment heterogenicity of m5C RNA methylation regulators in Triple-Negative breast cancer. Frontiers in Cell and Developmental Biology, 9, 657547. 10.3389/fcell.2021.657547 PubMedWeb of Science®Google Scholar Jin, S., Li, J., Shen, Y., Wu, Y., Zhang, Z., & Ma, H. (2022). RNA 5-Methylcytosine regulator NSUN3 promotes tumor progression through regulating immune infiltration in head and neck squamous cell carcinoma. Oral Diseases. https://doi.org/10.1111/odi.14357 10.1111/odi.14357 Web of Science®Google Scholar Li, C. H., Cheng, Y. W., Liao, P. L., Yang, Y. T., & Kang, J. J. (2010). Chloramphenicol causes mitochondrial stress, decreases ATP biosynthesis, induces matrix metalloproteinase-13 expression, and solid-tumor cell invasion. Toxicological Sciences, 116, 140–150. 10.1093/toxsci/kfq085 CASPubMedWeb of Science®Google Scholar Pan, J., Huang, Z., & Xu, Y. (2021). m5C RNA methylation regulators predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Frontiers in Oncology, 11, 657466. 10.3389/fonc.2021.657466 CASPubMedWeb of Science®Google Scholar Ren, H., Liu, C., Wu, H., Wang, Z., Chen, S., Zhang, X., Ren, J., Qiu, H., & Zhou, L. (2022). m(5)C regulator-mediated methylation modification clusters contribute to the immune microenvironment regulation of multiple myeloma. Frontiers in Genetics, 13, 920164. 10.3389/fgene.2022.920164 CASPubMedWeb of Science®Google Scholar Škrtić, M., Sriskanthadevan, S., Jhas, B., Gebbia, M., Wang, X., Wang, Z., Hurren, R., Jitkova, Y., Gronda, M., Maclean, N., Lai, C. K., Eberhard, Y., Bartoszko, J., Spagnuolo, P., Rutledge, A. C., Datti, A., Ketela, T., Moffat, J., Robinson, B. H., … Schimmer, A. D. (2011). Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell, 20, 674–688. 10.1016/j.ccr.2011.10.015 CASPubMedWeb of Science®Google Scholar Sun, Z., Xue, S., Zhang, M., Xu, H., Hu, X., Chen, S., Liu, Y., Guo, M., & Cui, H. (2020). Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene, 39, 6906–6919. 10.1038/s41388-020-01475-w CASPubMedWeb of Science®Google Scholar Wang, E., Li, Y., Ming, R., Wei, J., Du, P., Zhou, P., Zong, S., & Xiao, H. (2021). The prognostic value and immune landscapes of a m(6)A/m(5)C/m(1)A-Related LncRNAs signature in head and neck squamous cell carcinoma. Frontiers in Cell and Developmental Biology, 9, 718974. 10.3389/fcell.2021.718974 PubMedGoogle Scholar Zheng, H., Zhu, M., Li, W., Zhou, Z., & Wan, X. (2022). m(5) C and m(6) A modification of long noncoding NKILA accelerates cholangiocarcinoma progression via the miR-582-3p-YAP1 axis. Liver International: Official Journal of the International Association for the Study of the Liver, 42, 1144–1157. 10.1111/liv.15240 CASPubMedWeb of Science®Google Scholar Volume48, Issue3March 2024Pages 233-236 ReferencesRelatedInformation